Coriolis Pharma is a global contract research and development organization (CRDO) supporting the development of liquid and lyophilized drug products. We are committed to advancing biologics innovation through our exceptional drug product development, analytical, and manufacturing services. With a legacy of scientific excellence and a dedication to innovation, we have become the global partner for drug product innovators, supporting every phase of drug development from R&D to GMP. Our collaborative approach and profound scientific expertise establish us as a trusted partner from early-stage formulation to commercial manufacturing.

At Coriolis, we have a unique analytical portfolio of more than 200 different techniques - all performed in-house - to provide orthogonal and meaningful data. The in-house lyophilization development center enables our scientists to achieve time-saving and robust lyophilization cycles at laboratory, pilot and production scale. Dedicated GMP facilities allow us to perform lot release analysis and generate data to support regulatory submissions, as well as allow for customized "enhanced R&D" level studies.